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Abstract 
Background 
Being overweight is associated with both higher systolic blood pressure (SBP) and diastolic 
blood pressure (DBP) during pregnancy and increased risk of gestational hypertensive disorders. 
The objective of this study was to determine and quantify the effect of body mass index (BMI) 
on mean arterial pressure (MAP) at several time points throughout pregnancy in normotensive 
(NT) and chronic hypertensive pregnant (HT) women. 
Methods 
A prospective longitudinal study was carried out in 461 singleton pregnancies (429 low-risk and 
32 with chronic arterial hypertension), with measurements taken at the 1st, 2nd, and 3rd trimesters 
and at delivery. Linear mixed-effects regression models were used to evaluate the time-
progression of BMI, SBP, DBP and MAP during pregnancy (NT vs. HT). The longitudinal effect 
of BMI on MAP, adjusted for the hypertensive status, was investigated by the same 
methodology.  
Results 
BMI consistently increased with time in both NT and HT women. In contrast, MAP decreased 
during the first half of pregnancy, after which it increased until the moment of delivery in both 
groups. A 5-unit increase in BMI was predicted to produce an increase of approximately 1 
mmHg in population MAP values. This effect is independent from the time period and from 
hypertensive status. 
Conclusions 
In both NT and HT pregnant women, MAP is strongly (and significantly) influenced by 
increases in BMI. 
 
Keywords: Pregnancy; Hypertension; Body mass index; Mean arterial pressure 
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Resumo 
Introdução  
O excesso de peso está associado a pressão arterial mais elevada, quer sistólica, quer diastólica, 
assim como a risco aumentado de doenças hipertensivas durante a gravidez. O objetivo deste 
estudo é determinar e quantificar o efeito do índice de massa corporal sobre o comportamento da 
pressão arterial média em vários momentos da gravidez, em grávidas normotensas e hipertensas 
crónicas. 
Métodos 
Um estudo longitudinal e prospectivo foi realizado em 461 gestações únicas (429 gestações de 
baixo risco e 32 com hipertensão arterial crónica) cujas medições foram feitas no 1º,  2º e 3º 
trimestres, e no momento do parto. Foram usados modelos de regressão linear de efeitos mistos 
para determinar o índice de massa corporal, a pressão arterial sistólica, a pressão arterial 
diastólica e a pressão arterial média durante a gravidez em mulheres hipertensas e normotensas. 
O efeito longitudinal do índice de massa corporal sobre comportamento da pressão arterial média 
durante a gravidez, ajustado para o estado hipertensivo (normotensas vs. hipertensas), foi 
avaliado pela mesma metodologia.  
Resultados 
O índice de massa corporal aumenta consistentemente à medida a que o tempo avança em 
normotensas e hipertensas. Por outro lado, a pressão arterial média diminui durante a primeira 
metade da gravidez e, em seguida, sobe até ao momento do parto, em ambos os grupos. Espera-
se que um aumento de 5 unidades no índice de massa corporal produza um aumento de, 
aproximadamente, 1 mmHg nos valores da pressão arterial média na população. Este efeito é 
independente do tempo (fase da gravidez) e do estado hipertensivo (normotensas vs hipertensas). 
Conclusões 
Em ambos os grupos, quer em hipertensas, quer em normotensas, a pressão arterial média é 
significativamente influenciada pelo aumento do índice de massa corporal. 
 
Palavras-chave: Gravidez, Hipertensão, Índice de Massa Corporal, Pressão Arterial Média 
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Abreviations  
 
BIC - Bayesian Information Criterion 
BMI - Body Mass Index 
BP - Blood Pressure 
CHP-MJD - Centro Hospitalar do Porto, Unidade Maternidade Júlio Dinis 
CI - confidence interval 
DBP - Diastolic Blood Pressure 
GA - Gestational Age 
HT - Hypertensive 
LMEM - Linear Mixed-Effects (regression) Models  
MAP - Mean Arterial Pressure 
NT - Normotensive 
SBP - Systolic Blood Pressure 
SD - standard deviation. 
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Background  
Chronic arterial hypertension is a serious disorder; if left untreated, it can lead to serious health 
outcomes, mostly affecting target organs such as the heart, brain, kidney and retina (Messerli et 
al., 2007). Thus, women diagnosed with hypertension who become pregnant are at an increased 
risk for several pregnancy complications, including superimposed preeclampsia (Perni et al., 
2012; Seely & Ecker, 2014), foetal growth restriction (Chappel et al., 2008), preterm delivery 
(Bramham et al., 2014), placental abruption (Gilbert et al., 2007), and caesarean section 
(Bramham et al., 2014; Seely & Ecker, 2014). In addition, because chronic arterial hypertension 
affects 3-5% of pregnancies (Sibai, 2002; Lawler et al., 2007), it alone is a matter of concern and 
is increasingly encountered (Seely & Ecker, 2014). Obesity is the main risk factor contributing to 
this increased prevalence; its frequency is increasing among pregnant women, and it is a well-
known risk factor for both adverse maternal (Gaillard et al., 2011a) and neonatal outcomes 
(Crane et al., 2009; Aune et al., 2014). In fact, increased adiposity during normal pregnancy has 
been consistently associated with the same medical complications that are associated with 
chronic arterial hypertension in pregnant women (as described above) (Villamor et al., 2006). 
However, the mechanisms for these associations are not completely understood. 
Several studies have examined the effects of maternal weight on blood pressure levels during 
different periods of normal pregnancy (Miller et al., 2007; Helmreich et al., 2008; Crane et al., 
2009; Thompson et al., 2009; Mbah et al., 2010; Macdonald-Wallis et al., 2015). The results 
suggest that overweight, obesity and morbid obesity are associated with higher systolic (SBP) 
and diastolic blood pressure (DBP) during pregnancy and increased risks of gestational 
hypertensive disorders (Gaillard et al., 2011a).  
Nevertheless, studies that have effectively quantified the effects of weight gain on maternal 
blood pressure during pregnancy are lacking. It has been reasoned that additional data on the 
effects of increased body mass index (BMI) on mean arterial pressure (MAP) during normal 
pregnancy would be provided by a parallel study in women with long-term stable essential 
hypertension, which is a prevalent condition and a known risk factor for serious gestational 
disorders (Sibai, 2002; Bramham et al., 2014).  
Based on these considerations, this study aimed to determine and quantify the effects of BMI on 
MAP at several time points throughout pregnancy, in normotensive (NT) and chronic 
hypertensive (HT) pregnant women. 
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Methods  
The research protocol was approved by the local ethics committee (IRB protocol number: 133/10 
[086-DEFI/126-CES]) of the Centro Hospitalar do Porto – Unidade Maternidade Júlio Dinis 
(CHP-MJD), and all of the subjects provided informed consent upon receiving an adequate 
explanation of the study. The methods were carried out in accordance with the approved 
protocol. 
 
Study population and design 
Between January 2010 and December 2012 a total of 578 pregnant Caucasian women were 
recruited to participant in the study. According to local pregnancy health policies, the women 
were referred by their family doctors to the CHP-MJD. 
During their first appointment the women were observed by a senior specialist who reviewed 
their medical history, verified the absence of diabetes and other endocrine disorders, immune 
diseases, renal diseases, structural heart diseases, haematological conditions and chronic 
infections; gestational age (GA) was also checked by ultrasonography between 11 and 14 weeks 
(Robinson, 1973).  
The inclusion criteria were as follows: (1) singleton pregnancy and gestational age ≤ 14 weeks, 
and (2) healthy status or stable chronic arterial hypertension without known target organ 
involvement. 
The exclusion criteria were as follows: (1) patients with multiple gestations, coagulopathy, 
haematological pathology, diabetes, or any pregnancy-induced hypertension including 
preeclampsia, and (2) patients who refused to participate. Subjects were also excluded from the 
study if they had a preterm delivery (birth < 37th gestational week), were lost to follow-up, 
needed antihypertensive medication, or experienced foetal death.  
Chronic arterial hypertension was defined as a blood pressure of 140/90 mmHg on more than 
two occasions before 20 weeks of gestation or after 20 weeks of pregnancy if it persisted beyond 
12 weeks postpartum. However, only women with a history of chronic arterial hypertension prior 
to pregnancy were enrolled in the study.  
Before pregnancy, the majority of the patients required multiple medications, including thiazide, 
angiotensin converting enzyme inhibitor, angiotensin receptor blockers, or calcium channel 
blockers, to control their hypertension. After their first appointment, antihypertensive drugs were 
discontinued, and their blood pressure was closely monitored. Antihypertensive therapy was 
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restarted if a patient experienced a persistent diastolic pressure between 95 and 99 mmHg or if a 
systolic pressure ≥ 150 mmHg was observed at any time during their pregnancy.  
 
Definition of time-point measurements 
Anthropometric parameters and blood pressure were measured at the following four time points: 
12-14 weeks, 18-22 weeks, 29-33 weeks, and delivery. Each of these time points were converted 
to a time scale ranging from 0 to 1. Therefore, the initial time (i.e., before pregnancy) was 
considered to be 𝑡𝑖𝑚𝑒 = 0, and the time of delivery was considered to be  𝑡𝑖𝑚𝑒 = 1. 
 
Maternal anthropometrics 
The height (cm) and weight (kg) of each subject were measured without heavy clothing and 
shoes at each time point. Data about maternal weight just before pregnancy was obtained 
through questionnaires. Pre-pregnancy body mass index (BMI) was categorized into the 
following three categories: lean or normal (16-24 kg/m2), overweight (25-29 kg/m2) and obese 
(30-50 kg/m2).   
 
Blood pressure assessment 
The blood pressure (BP) was measured using an automated instrument (GE Healthcare 
Carescape™ V100 Vital Signs Monitor with DINAMAP Technology, Milwaukee, WI, USA); it 
was measured two consecutive times and averaged. Mean arterial pressure (MAP) was obtained 
according to the following formula: 𝑀𝐴𝑃 = 2×𝑑𝑖𝑎𝑠𝑡𝑜𝑙𝑖𝑐  𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒 + 𝑠𝑦𝑠𝑡𝑜𝑙𝑖𝑐  𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒3  
Prior to the measurement, each of the participants was seated and asked to relax for 5-10 
minutes. A cuff (CRITIKON Blood Pressure Cuffs®, GE Healthcare, 23-33 cm, Milwaukee, WI, 
USA) was placed around the non-dominant upper arm at the level of the heart, with the pressure 
cuff bladder midline over the brachial artery. A larger cuff (32-42 cm) was used in patients who 
had an upper arm that exceeded 33 cm. As enrolment in our study took place during pregnancy, 
we were unable to measure maternal blood pressure before pregnancy.  
 
Definition of normal pregnancy 
To restrict enrolment to patients with normal course pregnancies, we excluded 117 (20.2%) 
pregnant women who experienced any of the following events during their pregnancies: 
endocrine disorders, psychiatric disorders, history of bariatric surgery, secondary hypertension, 
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gestational hypertension/preeclampsia, preterm delivery, foetal growth restriction, 
antihypertensive medication use, multiple gestation, and foetal death. After these exclusions, 461 
women who had a normal pregnancy remained. Therefore, the study used basic inclusion 
criteria, including patients who were healthy or had stable chronic hypertension without known 
target organ involvement. 
  
Efforts to address potential sources of bias 
Any pregnant women who were seen by our clinical investigator during the study period were 
considered to be potentially eligible. The pregnancy consultations were randomly scheduled by 
the hospital administrative staff according to the availability of the clinical investigator (L.G-
M.). The patients were consecutively recruited, and the maternal anthropometric and blood 
pressure measurements were taken by experienced midwives who were unaware of the study 
protocol. All of the pregnancies were supervised by the same physician (L.G-M.), but the 
inclusion of pregnancies in the study was determined by another researcher who coordinated the 
review of each clinical case (A.C.). 
 
Statistical analysis 
Univariate analyses included the following standard statistical methods: (1) the chi-square or 
Fisher’s exact tests to compare frequencies from categorical variables or to study the 
independence between two factors; and (2) t-tests to assess the statistical significance of the 
difference between the means of two independent populations. 
Time was considered a continuous variable, with values 0, 0.3, 0.5, 0.8 and 1, in the BMI model 
[respectively 0.3, 0.5, 0.8 and 1 in the systolic blood pressure (SBP), diastolic blood pressure 
(DBP), MAP, and BMI effect on MAP (MAP-BMI) models]. Whilst 0 and 1 were arbitrarily 
chosen, the other points were proportional to the observational periods in the study; namely, 
before pregnancy, 12-14 weeks, 18-22 weeks, 29-33 weeks, and at delivery. Hypertension was a 
binary variable with normotensive status as the reference category. 
Linear mixed-effects (regression) models were used with the observations grouped at the 
individual level (Pinheiro & Bates, 2000). The random effects in the final models were identified 
either at the intercept alone, or at the intercept and the time coefficient. In the final models with 
two random effects, the best structure for the variance-covariance matrix of the random effects 
was shown to be that of a general positive definite matrix. Whenver the within-group error 
variance function had to be modelled, the assumption of independence did not seem to be 
compromised. For the same individual, the errors were assumed to be independent from the 
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random effects; for different individuals, the errors were assumed to be independent. The 
normality assumptions for the random effects and errors distributions were assessed through 
graphical analysis; however, for the BMI-time model, the responses had to be log-transformed 
for the normality of the errors distribution to not be rejected, and the normality assumption 
within the remaining models was confirmed. Due to sample size constraints, interaction terms 
were only considered in the MAP-BMI model.  
The final models were chosen based on the lowest Bayesian information criterion (BIC) or on 
the likelihood ratio test, as appropriate. All statistical analyses were carried out using R version 
2.12.1 (R Development Core Team). The significance level was set at 0.05. 
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Results  
Of the 461 women who were enrolled in the study, 429 were normotensive and 32 had chronic 
arterial hypertension.  
Figure 1 shows the number of pregnant women at each stage of the study. The main 
characteristics and pregnancy outcomes are shown in Table 1. In 31.9% of the cases, caesarean 
section was the mode of delivery; in more than 70% of those cases, the reason for receiving a 
caesarean section was prior caesarean delivery, dystocia, foetal distress, or breech presentation 
(Table 2). 
Table 3 describes the maternal anthropometrics and blood pressure during the study period. BMI 
consistently increased over time in both the NT and HT groups. In contrast, MAP decreased 
during the first half of pregnancy and then increased until the moment of delivery. 
 
BMI model 
The longitudinal model for BMI estimated a quadratic progression during pregnancy, with the 
same progression rate for both the NT and HT groups (Figure 2).  
The model for the BMI evolution during pregnancy, for any given rescaled time t and 
hypertensive status h (equal to 1 for HT and 0 for NT) of the ith woman, was as follows:  log(𝐵𝑀𝐼!) 𝑡, ℎ = 𝛽! + 𝑏!! + 𝛽!ℎ + 𝛽!𝑡 + 𝛽!𝑡! + 𝜀!                             (1) 
where the random effect 𝑏!! was assumed to follow a normal distribution, and the within-group 
error terms 𝜀! were assumed to follow a multivariate (5-dimensional) normal distribution with a 
first-order autoregressive model for their correlation structure. The corresponding estimates are 
presented in Table 4. The estimates for the correlation parameter (95% CI) and the within-group 
standard error (95% CI) were 0.943 (0.795, 0.985) and 0.103 (0.053, 0.198), respectively. All 
fixed effects are multiplicative because the response was log-transformed. 
The predicted BMI change during pregnancy consists of two increasing parabolic branches for 
each hypertensive status that are significantly different from one another; for any given time, the 
model predicts the hypertensive population to have a mean BMI that is significantly greater than 
that of the normotensive population.  
 
SBP model  
The model for SBP during pregnancy, for any given rescaled time t and hypertensive status h of 
the ith woman, was as follows:  𝑆𝐵𝑃! 𝑡, ℎ = (𝛽! + 𝑏!!)+ 𝛽!ℎ + (𝛽! + 𝑏!!)𝑡 + 𝛽!𝑡! + 𝛽!𝑡! + 𝜀!                             (2) 
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where the random effects (𝑏!! , 𝑏!!) were assumed to follow a bivariate normal distribution with a 
general positive-definite variance-covariance matrix, and the within-group error terms 𝜀! were 
assumed to follow a multivariate (4-dimensional) normal distribution. The estimates of the 
effects are presented in Table 4. The errors were found to have a variance function that is an 
exponent of the fitted values, with a coefficient (95% CI) estimated to be -0.031 (-0.037, -0.025). 
The correlation coefficient (95% CI) between the random effects was estimated to be -0.855      
(-0.887, -0.815).  
Two cubic parallel curves were obtained, one for each hypertensive status, and the SBP 
predictions were significantly higher for the HT group than the NT (Figure 3). For the 
normotensive population, the minimum and maximum expected values were 113.5 mmHg and 
123.9 mmHg, respectively, and they were attained at the (rescaled) time = 0.49 and time = 0.93, 
respectively. For the hypertensive population, the minimum and maximum mean values (attained 
at the same times) were predicted to be 129.5 mmHg and 139.9 mmHg, respectively.  
 
DBP model 
The model for DBP during pregnancy was of a similar form to (2). The obtained estimates for its 
effects are presented in Table 4. The correlation coefficient (95% CI) between the random 
effects was estimated to be -0.831 (-0.882, -0.760). The variance-covariance matrix of the within 
group errors was diagonal with a variance function that was constant for the hypertensive and 
normotensive groups. When the error variance within the normotensive population was 
standardized to 1, the estimated variance (95% CI) of the hypertensive population was 0.691 
(0.581, 0.821) times the variance prior to standardization. 
Two cubic parallel curves were expected, and the DBP values were significantly higher for the 
HT group than the NT group (Figure 3). For the normotensive population, the minimum and 
maximum mean values were predicted to be 63.21 mmHg and 66.38 mmHg, respectively, and 
they were attained at 𝑡 = 0.64 and 𝑡 = 1, respectively. For the hypertensive population, the 
minimum and maximum mean values (attained at the same times) were predicted to be 75.16 
mmHg and 78.34 mmHg, respectively. 
 
MAP model 
The model for MAP during pregnancy was again of a similar form to (2). Its estimates are 
presented in Table 4. The correlation coefficient (95% CI) between the two random-effects was 
estimated to be -0.871 (-0.828, -0.772). The variance-covariance matrix of the within group 
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errors was diagonal with a power variance function based on the fitted values; the variance 
function coefficient (95% CI) was estimated to be -1.632 (-2.206, -1.058). 
For the MAP model, two cubic parallel curves, one for each hypertensive status, were predicted, 
and the MAP values were significantly higher in the hypertensive group than the normotensive 
group (Figure 4). Between 12-14 weeks, the average MAP values were 82.42 mmHg and 95.43 
mmHg in the NT and HT groups, respectively. The values decreased during weeks 18-22, 
reaching a minimum of 80.43 mmHg and 93.44 mmHg in the NT and HT groups, respectively. 
After week 22, the values increased until delivery, reaching a maximum of 85.05 mmHg and 
98.06 mmHg, respectively.  
 
Adjusted BMI effect on MAP (MAP-BMI Model) 
The effect of BMI on MAP was obtained by adjusting the previous MAP model for the time-
dependent BMI variable. The predicted estimates for the mean and the estimates obtained for the 
model effects are presented in Table 4. The correlation coefficient (95% CI) between the random 
effects was estimated to be -0.832 (-0.875, -0.776). The variance-covariance matrix of the within 
group errors was diagonal with a variance function that was a power of the fitted values; the 
variance function coefficient (95% CI) was estimated to be -1.740 (-2.300, -1.180). 
The interaction between hypertensive status and BMI was not statistically significant (p=0.275). 
Adjusting for BMI led to very similar conclusions regarding the time and the hypertension 
effects on MAP. With respect to the BMI effect, a 1-unit increase in BMI was predicted to 
produce an increase of 0.21 mmHg in MAP, or equivalently, a 5-unit increase in BMI was 
predicted to produce an increase of approximately 1 mmHg in the population MAP values 
(Figure 5). This effect was independent of time period and hypertensive status; that is, regardless 
of the time period and hypertensive status, the predicted BMI effect on MAP remained the same.  
Parity was not statistically significant in any of the studied models (𝑝 = 0.443 for the BMI 
model; 𝑝 = 0.712 for the SBP model; 𝑝 = 0.471 for the DBP model; and 𝑝 = 0.729  for the 
MAP model).  
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Discussion 
Most of the normal increase in weight during pregnancy can be attributed to the foetus, breasts, 
and increases in extravascular fluid, and it causes inevitable demands on the hemodynamic 
balance of the pregnant. Consequently, blood pressure (BP) and maternal weight measurements 
play a central role in the adequate monitoring of pregnancy, during which profound metabolic 
and circulatory changes occur (Hermida et al., 2004; Miller et al., 2007; Thompson et al., 2009; 
ACOG, 2013). These cardiovascular changes begin early and include cardiac output increase, 
blood volume expansion, peripheral vasodilation and blood pressure reduction. Notably, half of 
the cardiac output increase occurs by 8 weeks of gestation, and cardiac output increases to 30-
50% (1.8 L/min) above the typical baseline (i.e., in non-pregnant status) (Katz et al., 1978; 
Capeless & Clapp, 1989; van Oppen, et al., 1996). As a consequence, in early pregnancy the 
uterus receives 3 to 6% of the cardiac output, whereas at 37-41 weeks it receives approximately 
12% of the cardiac output (Flo et al., 2010). This increase is crucial for an adequate perfusion of 
the developing feto-placental unit (Robson et al., 1989; Guedes-Martins et al., 2014a; Guedes-
Martins et al., 2014b).  
The results from this prospective study showed that, as in normotensive gestations (Strevens et 
al., 2001; Gaillard et al., 2011b), in chronic hypertensive pregnant women the shapes of the 
average SBP and MAP trajectories are characterized by a decrease until mid-pregnancy followed 
by an increase late in pregnancy. This pattern was much less noticeable for DBP, where little and 
almost no decreases in the average values were observed during pregnancy in the NT and HT 
groups, respectively. In addition, the differences in the SBP, DBP, and MAP trajectories between 
the NT and HT groups remained constant throughout pregnancy, and the trajectories temporally 
progress in a parallel fashion.  
To our knowledge, this is the first study to quantify the effects of BMI on MAP in chronic 
hypertensive pregnant women. We observed that higher BMI values were associated with higher 
MAP values in all trimesters of pregnancy in both the NT group and the HT group. In addition, 
regardless of the time period and hypertensive status, the predicted effect of BMI on MAP 
remained the same; a 5-unit increase in BMI was predicted to produce an increase of 
approximately 1 mmHg in MAP. 
Overall, our findings are in line with the robust association that has been found between 
increased adiposity and higher blood pressure in humans (Mokdad et al., 2003; Paradis et al., 
2004; Gregg et al., 2005). Particularly, previous studies have verified the blood pressure pattern 
that occurs during the trimesters of pregnancy in clinically healthy pregnant women (Hermida et 
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al., 2000; Hermida et al., 2001; Ayala et al., 2011) but not in a population of chronic 
hypertensive pregnant women. 
 
Statistics and methodological issues 
In all of the models, the two mean curves had a narrow 95% confidence interval. This suggests 
that most of the variability was captured by the random effects, which justifies their presence in 
the models. Moreover, the presence of random effects and the modelling of their variance-
covariance structures competed with the correlation structure of the errors, which turned out to 
have a simple structure. This phenomenon is well-known in the statistical literature on mixed-
effects models (Pinheiro & Bates, 2000). The fact that the best variance-covariance structure of 
the random effects was always a general positive definite matrix is in line with the values of the 
estimated correlation coefficients and variance estimates that were obtained in the various 
models. 
In the DBP model, the estimate for the time coefficient was not statistically significant; however, 
this is irrelevant because the estimates of the higher-order terms were all significant.  
No interactions between time and the hypertensive status of the women were considered. This 
was essentially due to the high-order polynomials (third order) that we found for the time 
variable combined with the sample size of the hypertensive group. Therefore, the predicted mean 
curves for the hypertensive population turned out to be a translation of the graphical mean values 
that were predicted for the normotensive population. However, this seemed to only negatively 
impact the fitting within the hypertensive population in the second evaluation period of the MAP 
model.  
Within the MAP model, the residuals of the hypertensive group were larger than those of the 
normotensive group. This result was related to the strength of the model, particularly the cubic 
time progression that ignored the hypertensive status of the women, up to adding a constant. The 
authors predicted that the presence of interaction terms in the model would improve the model 
predictions for the hypertensive population. However, this method would be inadequate given 
the relatively low sample of hypertensive women. Nonetheless, the sample size imbalance 
between the NT and HT participants is in accordance with the prevalence of chronic 
hypertension during pregnancy (Sibai, 2002; Lawler et al., 2007).  
The principal strength of this study was its prospective longitudinal design, which allowed for 
the assessment of data from the first trimester onwards. In addition, our analyses are based on 
blood pressure and weight measurements in the clinic (routine); therefore, they reflect the 
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patterns that occur in daily clinical practice as opposed to assessments that are made during trial 
conditions (Thompson et al., 2009).  
 
Weight gain and hypertension 
It is thought that weight gain causes hypertension (Calhoun & Grassi, 2004; Esler et al., 2008). 
In fact, in the general population, many cohort studies indicate that being overweight is a major 
risk factor for the development of hypertension and that weight loss lowers blood pressure in 
most hypertensive patients (Calhoun & Grassi, 2004; Messerli et al., 2007). This phenomenon 
has been attributed to increases in weight-related sympathetic activity, which in turn result in the 
down-regulation of β-adrenergic receptors; this down-regulation leads to a decreased 
thermogenic response and, consequently, to an increased propensity for weight gain and 
adiposity-related insulin resistance (Julius et al., 2000). This hypothesis has been strengthened 
by findings that hypertensive subjects experience a generalized decrease in β-adrenergic 
responsiveness, which modulates the development of obesity in hypertension (Valentini et al., 
2004; Masuo et al., 2005). As a corollary, sympathetic overactivation leads to hypertension and 
weight gain, and the weight gain further worsens the hypertension (Calhoun & Grassi, 2004; 
Newsom et al., 2010). Additionally, being overweight is a cause of chronic inflammation and 
oxidative stress, which are involved in the pathophysiology of hypertensive disorders during 
pregnancy (Guedes-Martins et al., 2013; Guedes-Martins et al., 2015). 
Our results suggest that preventive strategies prior to conception or adequate counselling during 
pregnancy should be applied to prevent obesity in reproductive-age women and to promote 
adequate increases in BMI during pregnancy.  
 
Study limitations 
There are several limitations to our study that should be acknowledged. First, the self-reporting 
of information on many covariates was generally avoided in this study, which limited the 
availability of detailed information about a large number of potential confounding factors, as 
certain adverse lifestyle-related determinants of hypertension. Second, information on maternal 
pre-pregnancy weight was obtained through a questionnaire; thus, it tended to be underestimated 
and we cannot exclude the possibility of minor misclassification. Third, the study comprised 
uneventful pregnancies, and thus the results cannot be extrapolated to patients with other forms 
of hypertensive disease during pregnancy. For the same reasons, we are not able to analyse the 
effect of BMI gain and the risk of gestational hypertensive disorders or any adverse pregnancy 
outcomes. Fourth, we were not able to measure MAP changes in relation to the distribution of 
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maternal fat, which is more related to endothelial dysfunction, although BMI is highly correlated 
with visceral fat (Sidney et al., 1999). Fifth, the generalizability of our investigation is also 
limited because our participants were all White women. Sixth, because we did not assess 
pregnancies with adverse outcomes, the clinical relevance of our findings remains uncertain.  
 
Conclusions 
This study provides evidence that, in normotensive and chronic hypertensive pregnant women, 
MAP is strongly influenced by increases in BMI starting in the first trimester and lasting until 
delivery.  
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Figure legends 
 
 
Figure 1. Study flowchart: number of pregnant women at each stage of the study. * Any pregnant women who were 
seen by our clinical investigator during the study period were considered to be potentially eligible. 
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Figure 2. Expected body mass index (BMI) over time in the hypertensive (triangles) and normotensive (circles) 
women. The 95% confidence intervals for the respective predictions are indicated (dashed lines).  
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Figure 3. Expected systolic (SBP) and diastolic blood pressure (DBP) over time in the hypertensive and 
normotensive women. The 95% confidence intervals for the respective predictions are indicated (dashed lines). 
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Figure 4. Expected mean arterial pressure (MAP) over time in the hypertensive (triangles) and normotensive 
(circles) women. The 95% confidence intervals for the respective predictions are indicated (dashed lines).  
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Figure 5. Expected effects of body mass index on mean arterial pressure, at different time points during pregnancy, 
in the hypertensive and normotensive pregnant women. Solid line, 12-14 weeks; dashed line, 18-22 weeks; dotted 
line, 29-33 weeks; dashed-dotted line, at delivery. The effect is always the same, geometrically reflected on a unique 
slope, regardless of the time period and hypertensive status.  
 
Tables 
 
Table 1. Demographic characteristics and pregnancy outcomes of the 461 women included in the analysis. 
 
   Normotensive Hypertensive   BMI (kg/m2)  
 n (%) p-value1  n=429 n=32 p-value2  16-24 25-29 30-50 p-value3 
Age years [years (%)] 
16-24 102 (22%) 
<0.001 
 102 (24%) 0 
<0.001 
 66 (26%) 20 (17%) 16 (18%) 
0.047 25-35 303 (66%)  285 (66%) 18 (56%)  164 (65%) 78 (66%) 61 (67%) 
36-43 56 (12%)  42 (10%) 14 (44%)  22 (9%) 20 (17%) 14 (15%) 
             
Parity [n (%)] 
0 238 (52%) 
0.485 
 226 (53%) 12 (38%) 
0.140 
 135 (54%) 54 (46%) 49 (54%) 
0.335 
≥1 223 (48%)  203 (47%) 20 (62%)  117 (46%) 64 (54%) 42 (46%) 
             
Gestational age at delivery, weeks [mean (SD)] 39.22 (1.20) - NA  39.24 (1.17) 38.93 (1.68) 0.308  39.21 (1.18) 39.20 (1.28) 39.25 (1.22) 0.960 
             
Foetal sex [n (%)] 
Female 245 (53%) 
0.177 
 229 (53%) 16 (50%) 
0.852 
 129 (51%) 62 (53%) 54 (59%) 
0.405 
Male 216 (47%)  200 (47%) 16 (50%)  123 (49%) 56 (47%) 37 (41%) 
             
Birth weight at delivery, g [mean (SD)] 3128 (334) - NA  3136  (329) 3007 (379) 0.070  3116 (350) 3167 (321) 3108 (301) 0.042 
             
Apgar Score Index at 5’ 
<7 0 
NA 
 0 (0%) 0 (0%) 
<0.001 
 0 0 0 
<0.001 
7 - 10 461 (100%)  429 (100%) 32 (100%)  252 (100%) 118 (100%) 91 (100%) 
 
1 p - tested equality of population frequencies amongst the different categories of a variable; 2 p - tested homogeneity of the proportions between HT (hypertensive) and NT 
(normotensive); 3 p - tested homogeneity of the proportions between normal weight, overweight and obese; BMI, body mass index; SD, standard deviation. 
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Table 2. Indication for caesarean sections (𝐧 = 𝟏𝟒𝟕) in the study sample. 
  Caesarean deliveries (%)* 
  All (%) n=147 
Normotensive (%) 
n=135** 
Hypertensive (%) 
n=12† 
Primary 
Dystocia 29 (20) 27 (20)  2 (17) 
Non-reassuring foetal heart rate 21 (14) 19 (14) 2 (17) 
Abnormal presentation 18 (12) 17 (13) 1 (8) 
Unsuccessful trial of forceps or vacuum 14 (10) 13 (10) 1 (8) 
Repeat 
No VBAC attempt 40 (27) 36 (27) 4 (33) 
Failed VBAC 16 (11) 15 (11) 1 (8) 
Unsuccessful trial of forceps or vacuum 9 (6) 8 (6) 1 (8) 
 
*Data are shown as absolute (relative, %) frequencies; VBAC, vaginal birth after caesarean; The sums of the relative frequencies in the categories were 101%* and 99%† due 
to rounding. 
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Table 3. Description of maternal anthropometrics and blood pressure at each study period. 
 Period Normotensive Hypertensive 
Weight  
kg, mean (SD) 
Pre-pregnancy 
12-14 weeks 
18-22 weeks 
29-33weeks 
At delivery 
64.09 (12.65) 
65.94 (13.03) 
69.82 (13.69) 
75.92 (13.99) 
80.96 (14.12) 
75.17 (17.06) 
76.83 (17.67) 
78.69 (16.96) 
85.03 (16.34) 
92.95 (16.93) 
    
BMI  
kg/m2, mean (SD) 
Pre-pregnancy 
12-14 weeks 
18-22 weeks 
29-33weeks 
At delivery 
25.10 (5.18) 
25.83 (5.38) 
27.35 (5.66) 
29.75 (5.86) 
31.73 (5.98) 
28.76 (6.54) 
29.40 (6.79) 
30.12 (6.52) 
32.56 (6.39) 
35.59 (6.59) 
    
SBP  
mmHg, mean (SD) 
Pre-pregnancy 
12-14 weeks 
18-22 weeks 
29-33weeks 
At delivery 
- 
119.79 (10.62) 
114.37 (10.28) 
119.91 (11.03) 
121.50 (11.66) 
- 
136.22 (9.36) 
123.65 (9.29) 
140.81 (8.52) 
143.75 (8.84) 
    
DBP 
mmHg, mean (SD) 
Pre-pregnancy 
12-14 weeks 
18-22 weeks 
29-33weeks 
At delivery 
- 
63.05 (8.15) 
64.09 (11.44) 
62.93 (10.85) 
66.13 (11.54) 
- 
76.09 (6.89) 
72.62 (6.84) 
78.94 (8.05) 
76.88 (9.21) 
    
MAP  
mmHg, mean (SD) 
Pre-pregnancy 
12-14 weeks 
18-22 weeks 
29-33weeks 
At delivery 
- 
81.96 (6.75) 
80.85 (8.52) 
81.93 (8.28) 
84.59 (8.82) 
- 
96.14 (6.01) 
86.64 (4.45) 
99.56 (6.45) 
99.16 (6.91) 
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; SD, standard deviation. 
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Table 4. Estimates for the fixed and random effects identified by the (longitudinal) mixed-effects model for body mass index (BMI), systolic blood pressure (SBP), diastolic 
blood pressure (DBP), mean arterial pressure (MAP), and adjusted BMI effect on MAP (MAP-BMI), in normotensive (NT) and chronic hypertensive (HT) women. The NT 
women were designated as the reference category. 
 
 Fixed Effects Coefficient Standard Error p-value Random effects Standard Deviation (95% CI) 
       
BMI 
Intercept 3.206 0.009 <0.001 Intercept 0.158 (0.117, 0.212) 
HT (vs. NT) 0.124 0.034 <0.001 - - 
Time 0.067 0.006 <0.001 - - 
(Time)2 0.167 0.006 <0.001 - - 
       
SBP 
Intercept 183.644 3.692 <0.001 Intercept 11.237 (10.058, 12.553) 
HT (vs. NT) 16.034 1.166 <0.001 - - 
Time -346.487 20.000 <0.001 Time 18.351 (16.601, 20.285) 
(Time)2 539.023 32.389 <0.001 - - 
(Time)3 -253.282 16.192 <0.001 - - 
       
DBP 
Intercept 57.967 3.905 <0.001 Intercept 7.036 (5.702, 8.683) 
HT (vs. NT) 11.954 0.974 <0.001 - - 
Time 32.958 21.255 0.121 Time 15.327 (13.516, 17.380) 
(Time)2 -63.105 35.012 0.072 - - 
(Time)3 38.120 17.863 0.033 - - 
       
MAP 
Intercept 96.181 2.902 <0.001 Intercept 6.719 (5.802, 7.780) 
HT (vs. NT) 13.014 0.851 <0.001 - - 
Time -74.081 15.754 <0.001 Time 12.745 (11.443, 14.196) 
(Time)2 107.357 25.840 <0.001 - - 
(Time)3 -44.409 13.116 0.001 - - 
       
MAP-BMI 
Intercept 91.209 3.026 <0.001 Intercept 6.509 (5.604, 7.562) 
HT (vs. NT) 12.283 0.837 <0.001 - - 
BMI 0.210 0.039 <0.001 - - 
Time -75.634 15.635 <0.001 Time 12.713 (11.422, 14.150) 
(Time)2 108.038 25.629 <0.001 - - 
(Time)3 -45.221 13.004 0.001 - - 
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Abstract
Purpose The present study compared the Doppler flow
pulsatility indices (PI) in the uterine arteries (UtA) during
the puerperium between healthy women and those with
stage-1 essential hypertension who had uncomplicated
pregnancies and delivered by elective caesarean section.
The change in the mean arterial pressure (MAP) and body
mass index (BMI) over time was also assessed.
Methods A longitudinal and prospective study was per-
formed in singleton pregnancies of 28 normotensive (NT)
and 24 hypertensive (HT) women. The UtA-PI was mea-
sured immediately before caesarean section (time 0) and at
1 week (time 1) and 4 weeks (time 2) postpartum. The
presence or absence of early diastolic notches was recor-
ded. The change in the MAP, BMI, and UtA-PI over time
and between the two populations was modelled through
multivariate linear regression using the generalised least
squares.
Results In both groups, the UtA-PI significantly increased
from time 0 to time 1 (p \ 0.05) and time 2 (p \ 0.05).
Stage-1 hypertension did not change the trend but did
increase the UtA-PI magnitude (p \ 0.05). The presence of
uterine artery notching increased over time, from 6 to
98 %, in both groups (p \ 0.001); however, in the HT
group, at time 1, the majority of women exhibited positive
notching [92 % (HT) vs 57 % (NT), p = 0.013].
Conclusions Chronic stage-1 hypertensive women with
normal pregnancy outcomes exhibited a progressively
increasing postpartum UtA impedance. This trend also
occurred in normotensive women, albeit at a significantly
lower magnitude.
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Introduction
Soon after a pregnancy is established, there is a progressive
increase in the blood demand in the pelvic canal to meet
the requirements of the growing uterus and foetus. The
uterine artery (UtA) in particular undergoes important
functional changes that can be assessed using computerised
analysis of its blood velocity spectrum measured by
Doppler ultrasound. This procedure has expanded quite
rapidly in obstetrics recently due to its non-invasive nature
and the relative simplicity of currently available devices
and techniques. Moreover, the technique enables quanti-
tative measurement of the impedance as the pulsatility (PI)
and resistance (RI) indices, which are important for func-
tional categorization of the uterine artery. The PI is con-
sidered to describe the shape of the velocity waveform
much better than other indices [1].
The UtA impedance has been measured in reproductive-
age women before pregnancy [2, 3], during pregnancy [1,
4], and at delivery [5, 6]. In non-pregnant women, the
uterine artery flow velocity during systole rapidly rises and
falls, and is followed by a notch during early diastole [2];
during the menstrual cycle, the impedance decreases during
the luteal phase before increasing as menstruation
approached in parallel with the increasing plasma proges-
terone and oestradiol concentrations, which rise as
implantation nears [3, 7].
During pregnancy in healthy women, the uterine artery
blood volume increases and is paralleled by a progressive
decrease in the blood flow impedance beginning at early
gestation [4] and lasting throughout the remaining preg-
nancy until term [1]. This is thought to result from the
impressive structural changes at the placental bed. The
placenta-derived trophoblastic cells migrate across the
decidua layer to the inner third of the myometrium to reach
the maternal spiral arteries, which are the distal branches of
the uterine artery; the trophoblasts then invade the vascular
walls and replace most of the muscular and endothelial
cells [8, 9]. This migration renders the uterine arteries low-
impedance/high-capacitance vessels, and the PI decreases.
In contrast, a sustained or increased UtA-PI is thought to
have prognostic value for the development of uterine dis-
orders such as preeclampsia (PE) [10, 11] and placental
abruption [12, 13], and is correlated with adverse perinatal
outcomes [14–16].
Upon delivery, the hemodynamic features reverse; the
cardiac output and heart rate fall, and in most studies, the
uterine artery impedance increases due to a sudden drop in
nutritional demand. In fact, increased vascular resistance
reportedly begins very early postpartum and progresses
thereafter [17–19]; the UtA protodiastolic notch also
reappears in tandem in a progressive fashion [19]. In
contrast to the wealth of studies performed during preg-
nancy, the changes in the pelvic circulation puerperium
have received much less attention. However, serious
pathological conditions can arise during this period
including haemorrhage, anaemia, infection, disabling pain,
and unexpected PE. Preeclampsia is particularly important
because it is first recognised at the postpartum period in
approximately 5 % of cases, and its morbidity and mor-
tality may be considerable [20].
Thus, it is important to have a better understanding of
the changing pelvic features, circulatory or otherwise,
during this postpartum period. Apart from obtaining data
from normotensive women, we reasoned that additional
information on the uterine artery performance during
pregnancy could be provided by a parallel study in
women with chronic stable hypertension because hyper-
tension is a prevalent condition and a known risk factor
for serious disorders of the pregnancy, including PE [21–
23]. Therefore, in the present study, we compared the
Doppler flow impedance in the uterine arteries post-
partum in healthy, normotensive women to those with
stage-1 essential hypertension who had uncomplicated
pregnancies and a normal puerperium period. To exclude
the expected confounder effect of the delivery method on
the postpartum uterine artery impedance behaviour, only
women undergoing elective caesarean section were
included.
Materials and methods
Subjects
This study was approved by the local ethics committee of
Centro Hospitalar do Porto-Unidade Maternidade Ju´lio
Dinis, and all subjects provided informed consent [Ref.
150-13(096-DEFI/122-CES)].
From January 2010 to December 2012, women with
singleton pregnancies at term and scheduled for elective
caesarean section (due to foetal breech presentation, sus-
pected cephalopelvic disproportion, or previous caesarean
section) were recruited and allocated into two groups. The
first group included healthy women who had uneventful
pregnancies. The second comprised women with a history
of chronic arterial hypertension prior to pregnancy.
Acceptable medication in both groups was folic acid,
vitamin, and iron supplements. Additionally, all hyperten-
sive pregnant women received acetylsalicylic acid (100 mg
per day) and methyldopa (500–750 mg divided into two to
three doses per day). Oral acetylsalicylic acid was
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administered starting at 6–14 weeks of gestation and con-
tinued until the day of delivery, according to our institu-
tional protocol for managing chronic hypertensive pregnant
women. Before pregnancy, the majority of patients
required multiple medications to control their hypertension
including thiazide, angiotensin-converting enzyme inhibi-
tor, angiotensin receptor blockers, or calcium channel
blockers. After the first appointment, antihypertensive
drugs were discontinued, and the blood pressure response
was closely monitored. Antihypertensive therapy was rein-
stituted if persistent diastolic pressures of 95–99 mmHg or a
systolic pressure C150 mmHg was observed at any time
during pregnancy.
Gestational age was determined by ultrasonography
between 11 and 14 weeks. Biometric data, blood pressure,
uterine artery Doppler flow analysis, and the body mass
index (BMI) were measured at three time points: imme-
diately before caesarean section (Time 0), and 1 (Time 1)
and 4 (Time 2) weeks after delivery. On the day of cae-
sarean section, all women were observed by a senior spe-
cialist who reviewed the patient’s history and verified the
absence of diabetes and other endocrine disorders, immune
diseases, renal, structural heart diseases, haematological
conditions, and chronic infections. Patients in labour, those
with ruptured membranes, those with multiple foetuses,
and those receiving b-tocolytic drugs, as well as those who
had reported per-operative complications were excluded.
Foetal disorders or newborn abnormalities, verified by a
neonatologist at birth and 1 month later, were additional
criteria for exclusion.
Blood pressure assessment
The blood pressure (BP) was measured immediately before
Doppler flow assessment using an automated instrument
(GE Healthcare CarescapeTM V100 Vital Signs Monitor
with DINAMAP Blood Pressure) three consecutive times
and averaged. Blood pressure was expressed as the mean
arterial pressure (MAP) according to the formula:
MAP ¼ 2  diastolic pressureð Þ þ systolic pressure
3
:
Doppler flow assessment
The Doppler flow evaluation of right and left UtA was
performed at the three time points employing a 4 MHz
convex transabdominal probe at baseline (Time 0) and a
transvaginal transducer at Times 1 and 2 (GE Healthcare
Technologies, Voluson 730 Pro, USA). Nursing mothers
were required to abstain from breastfeeding for at least
30 min prior to examination.
For the UtA transabdominal evaluation (Time 0), the
probe was placed on the lower abdominal quadrants and
angled medially, and colour Doppler imaging was used to
localise the UtA as it crossed over the external iliac artery.
In all cases, an angle less than 30 was assured before the
pulsed Doppler probe was placed over the entire vessel
width. Angle correction was then applied, and the signal
was updated until three similar consecutive waveforms
were observed. The left and right uterine artery pulsatility
(UtA-PI) indices were calculated using the device software.
For the UtA transvaginal assessment (Times 1 and 2), a
sagittal section of the uterus was obtained, and the cervical
canal and internal cervical ostium were identified. The
transducer was gently tilted from side to side, and colour
flow mapping was used to identify each uterine artery
alongside the cervix and uterus at the level of the internal
ostium. Pulsed wave Doppler was used with the sampling
gate set at 2 mm to image the entire vessel and ensure that
the angle of insonation was\30. Finally, the mean UtA-PI
of the left and right arteries was calculated (Fig. 1).
The presence or absence of a bilateral early protodia-
stolic notch in the UtA was noted. A positive notch was
defined as a persistent decrease in the blood flow velocity
during early diastole below the diastolic peak velocity in at
least one UtA Doppler ultrasound spectrum. Absence of the
notch was defined by its bilateral absence.
All measurements were made by a single investigator
with extensive experience in Doppler ultrasound to avoid
inter-observer variability. Intra-observer reliability was
estimated from two consecutive readings among the first 40
PI recordings in the UtA (20 transabdominal and 20
transvaginal).
Statistical analysis
Univariate data analysis was performed using the Chi
square test or Fisher’s test as appropriate to determine
independence amongst two factors, the t test for the dif-
ference in means from two independent populations, and
one-way analysis of variance for repeated measurements.
Tukey’s multiple comparisons test was used to assess sta-
tistically significant differences across more than two
means in paired populations.
The change in the UtA-PI, MAP, and BMI over time in
each group was modelled through multiple linear regres-
sion. The generalised least squares with maximum likeli-
hood estimation method was applied to correlated and
heteroscedastic errors following a normal distribution. For
each dependent variable, the best model was chosen based
on the lowest value of the Bayesian Information Criterion
(BIC).
For each woman with a hypertensive status h (equal to 1
for hypertensive women and 0 otherwise), at continuous
time t representing the number of weeks after labour, the
MAP was modelled by the following equation:
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MAP h; tð Þ ¼ b0 hð Þ þ b1 hð Þt þ e: ð1Þ
Both the intercept and the time-slope coefficient are
linear functions of the hypertensive status, and e represents
the errors of the model. The errors correlation structure had
compound symmetry within each hypertensive status. Time
was coded as 0, 1, or 4, and was considered a continuous
variable to reflect the real time differences between the
three evaluation periods.
For BMI, the best fitted model was as follows:
logðBMI h; tÞð Þ ¼ b0ðhÞ þ b2t þ e ð2Þ
with the BMI logarithm linear in both hypertensive status
and time.
The model obtained for the pulsatility index had an
identical structure to model (2). However, the errors from
model (2) had an identical compound symmetry structure
within each individual and different variances depending
on the hypertensive status, but the errors correlation
structure in the PI model had a compound symmetry within
each hypertensive status and different error variances
according to the hypertensive status.
The intraclass correlation coefficient (ICC) and 95 %
confidence intervals were calculated using a two-way
mixed-effects model with absolute agreement. The reli-
ability coefficient, which is the difference value excee-
ded by only 5 % of measurement pairs on the same
subject, was calculated as 1.96 times the standard
deviation of the difference between pairs of repeated
measurements.
Statistical analyses were performed using the R language
and software environment for statistical computation, ver-
sion 3.0.11 [24]. The significance level was fixed at 0.05.
Fig. 1 a Uterine artery (UtA) depicted in colour flow map. Typical
Doppler shift spectra recorded at time 0 (b), 1 week (c), and 4 weeks
(d) after delivery. In b waveforms, the velocity gradually decreased
from its systolic peak, and a continuous forward flow was observed
during diastole. In c and d, the waveforms show a notch before
beginning continuous diastole forward flow. Pulsatility index (PI), the
measure of impedance of blood flow distal to the sampling point, was
calculated according to the formula: PI ¼ ðsdÞ
mean
, where s is the peak
systolic, d is the minimum end-diastolic, and mean is the average
maximum Doppler shift frequency over the cardiac cycle. c early
diastolic, x maximum diastolic frequency
Arch Gynecol Obstet
123
Results
A total 84 pregnant women at term were initially eligible
based on the established inclusion criteria. However, 32
(38.1 %) were later excluded: 7 patients were in early
labour; 5 had multiple pregnancies; 4 had diabetes; 3 pre-
sented technical difficulties during PI measurement in the
uterine/umbilical arteries; 2 had suspected preeclampsia; 8
were lost during follow-up; and 3 were excluded because
of puerperium complications (2 had prolonged postpartum
haemorrhage and 1 had surgical site infection).
Among the 52 enrolled women, 28 (53.8 %) were
normotensive (NT), and 24 (46.2 %) had stage-1 chronic
arterial hypertension (HT) (Table 1). The patient ages
ranged from 17 to 42 years, and 67 % were less than
35 years. This was the first pregnancy in 65 % of the
women. All delivered at term with a mean gestational age
at delivery of 39.5 weeks [standard deviation (SD) 0.85].
There were significant differences between the NT and
HT groups in parity (nulliparous predominated the HT
group) and BMI (higher classes predominated the HT
group).
During the puerperium, the presence of uterine artery
notching increased over time from 6 to 98 % (Table 2) in
both groups (p \ 0.001). During the first (week 0) and third
(week 4) time points, there were no significant differences
between the NT and HT groups in the presence of notch-
ing; however, in the HT group, the majority of women
exhibited positive notching at the second (week 1) time
point [92 % (HT) vs 57 % (NT)], and the difference was
statistically significant (p = 0.013). The mean (SD) of the
MAP, BMI, and UtA-PIs at each time point and in each
group are shown in Table 3. The crude effect of time on the
mean MAP, BMI, and UtA-PIs is shown in Fig. 2. There
was an overall decreasing trend in the mean MAP and
BMI, and an increasing trend in the mean UtA-PI over time
(Fig. 2a, b, and c, respectively).
The reliability coefficients were 0.080 and 0.457 for the
transabdominal and transvaginal UtA-PI measurements,
respectively. The intraclass correlation coefficient for the
intra-observer reliability was 0.976 for the transabdominal
(95 % CI 0.933–0.989) and 0.858 for the transvaginal
(95 % CI 0.642–0.944) assessments, which is quite high
[25].
Multivariate analysis
The net effect of time on the MAP, BMI, and UtA-PI was
considered merely indicative; therefore, multivariate anal-
yses were performed by adjusting the effect to potential
Table 1 Demographic
characteristics of the study
population
BMI body mass index, GA
gestational age, SD standard
deviation
a BMI: measurement at time 0
b Tests homogeneity of
proportions between the
hypertensive and normotensive
populations
c The summed relative
frequencies in the three
categories was 101 % due to
rounding
All (n = 52) Normotensive
(n = 28)
Hypertensive
(n = 24)
p valueb
Age (intervals in years)
17–24 8 (15 %) 3 (11 %) 5 (21 %) 0.359
25–34 27 (52 %) 17 (61 %) 10 (42 %)
35–42 17 (33 %) 8 (28 %) 9 (37 %)
Education level (years)
\7 4 (8 %) 1 (4 %) 3 (12 %) 0.386
7–9 10 (19 %) 4 (14 %) 6 (25 %)
10–12 23 (44 %) 13 (46 %) 10 (42 %)
[12 15 (29 %) 10 (36 %) 5 (21 %)
Smoking
No 46 (88 %) 25 (89 %) 21 (87 %) 1.000
Yes 6 (12 %) 3 (11 %) 3 (13 %)
Parity
0 34 (65 %) 14 (50 %) 20 (83 %) 0.026
C1 18 (35 %) 14 (50 %) 4 (17 %)
Body mass indexa (kg/m2)
18–24 19 (37 %)c 14 (50 %) 5 (21 %) 0.009
25–29 14 (27 %)c 9 (32 %) 5 (21 %)
30–51 19 (37 %)c 5 (18 %) 14 (58 %)
GA at delivery (weeks ± SD) 39.5 (0.85) 39.5 (0.87) 39.5 (0.85) 0.840
Birth weight at delivery (g),
mean (SD)
3,239.4 (405.36) 3,209.5 (432.71) 3,274.4 (377.08) 0.566
Arch Gynecol Obstet
123
confounders and accommodating the study design. Known
confounding variables such as maternal age, BMI, and
parity were also considered in the analysis; they were not
statistically significant and were not considered in the final
model.
MAP and BMI models
Although the mean MAP significantly decreased over
time (p \ 0.05) in the HT group, the time variable failed
to have a significant effect in the NT group (Fig. 3a). The
corresponding model is described in the ‘‘Statistical ana-
lysis’’ section; estimates of the coefficients and respective
95 % confidence intervals are presented in Table 4. The
predicted BMI and the 95 % confidence intervals for the
NT and HT group over time are shown in Fig. 3b. In both
groups, the BMI exhibited a decreasing trend, but there
was no significant difference between the NT and HT
groups. Estimates of the coefficients and 95 % confidence
Table 2 Absolute (relative, %) frequencies for positive notching of uterine arteries in normotensive and hypertensive women
Time (weeks) All (n = 52) p valuea Normotensive (n = 28) Hypertensive (n = 24) p valueb
0 3 (6 %) \0.001 1 (4 %) 2 (8 %) 0.590
1 38 (73 %) \0.001 16 (57 %) 22 (92 %) 0.013
4 51 (98 %) \0.001 27 (96 %) 24 (100 %) 1.000
a Tests the equality of population frequencies amongst positive and negative notching
b Tests the homogeneity of proportions between the hypertensive and normotensive populations
Table 3 Mean (standard deviation) MAP, BMI, and PI at each time
point in the whole sample and stratified by hypertensive status
Weeks Time points
0 1 4
All (n = 52)
MAP 95.692 (13.189) 94.474 (12.486) 90.526 (9.911)
BMI 31.403 (5.488) 30.331 (5.449) 28.788 (5.522)
UtA-PI 0.808 (0.208) 1.301 (0.338) 1.915 (0.383)
Normotensive (n = 28)
MAP 87.048 (9.070) 84.738 (6.868) 84.917 (7.446)
BMI 30.115 (5.759) 29.322 (5.805) 27.263 (5.630)
UtA-PI 0.746 (0.227) 1.134 (0.292) 1.832 (0.438)
Hypertensive (n = 24)
MAP 105.778 (9.594) 105.833 (6.348) 97.069 (8.352)
BMI 32.907 (4.843) 31.507 (4.859) 30.568 (4.927)
UtA-PI 0.879 (0.159) 1.495 (0.283) 2.013 (0.286)
MAP mean arterial pressure, BMI body mass index, UtA-PI uterine
artery pulsatility index
Fig. 2 Mean (±standard deviation) MAP (a), BMI (b), and UtA-PI (c) at each time point in the entire sample. MAP mean arterial pressure, BMI
body mass index, UtA-PI uterine artery pulsatility index
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intervals for the corresponding model are presented in
Table 5.
UtA pulsatility indices
The predicted and observed mean UtA-PI in the NT and
HT groups are depicted in Fig. 4. In both groups, the
uterine artery impedance showed a significant increase
over time (p \ 0.05). Additionally, the PI in the HT group
was significantly higher over time compared with the NT
group. The estimated coefficients of the regression model
used to predict the PI at the different covariates combina-
tions are presented in Table 6.
Discussion
During pregnancy, remarkable circulatory changes occur in
the pelvis because the foetus has increased nutritional
demands that the uterine circulation must accommodate.
As expected, the uterine artery, as the immediate
Fig. 3 Predicted mean arterial pressure (a) and body mass index
(b) over time in normotensive (dashed line, circles) and hypertensive
(solid line, triangles) women. The 95 % confidence intervals for the
respective predictions are indicated (dashed bands)
Table 4 Estimated coefficients and correlation of the regression
model predicting the MAP at different covariates combinations
Covariates Coefficient 95 % CI
Intercept 86.338* 84.533, 87.922
Hypertension 20.581* 17.989, 23.173
Time -0.396 -1.413, 0.621
Hypertension 9 time -1.953* -3.449, -0.456
MAP mean arterial pressure, CI confidence interval
* p \ 0.05
Table 5 Estimated coefficients, correlation, and variance parameters
of the regression model predicting the BMI at different covariates
combinations
Covariates Coefficient 95 % CI
Intercept 3.387* 3.309, 3.465
Hypertension 0.084 -0.011, 0.179
Time -0.025* -0.031, -0.020
Hypertension 9 time 0.008* 0.001, 0.015
Correlation parameter 0.955
Variance factor for hypertension 0.640
BMI body mass index, CI confidence interval
* p \ 0.05
Fig. 4 Predicted mean pulsatility (PI) index of the uterine artery over
time in normotensive (dashed line, circles) and hypertensive (solid
line, triangles) women. The 95 % confidence intervals for the
respective predictions are indicated (dashed bands)
Table 6 Estimated coefficients, correlation, and variance parameters
of the regression model predicting the uterine artery PI at different
covariates combinations
Covariates Coefficient 95 % CI
Intercept -0.215* -0.254, -0.293
Hypertension 0.197* 0.177, 0.217
Time 0.197* 0.173, 0.220
Correlation parameter -0.012
Variance factor for hypertension 0.821
PI pulsatility index, CI confidence interval
* p \ 0.05
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intervenient in this process, has become an important target
in obstetrical Doppler ultrasound studies. Several reports
performed at different gestational ages have shown that the
uterine artery impedance provides relevant predictive
information on serious maternal and foetal complications.
As a result, UtA-PI and notch assessment has been rec-
ommended for use in daily clinical practice [16]. Although
the value of UtA impedance assessment during pregnancy
is unquestionable, its postpartum utility is less clear and
has received less attention. Yet, the ability to predict cer-
tain postpartum pathologies would be immensely useful;
therefore, appropriate prognostic tools are needed. Among
the potential complications, PE, postpartum haemorrhage,
retained placental tissue, and infection are particularly
relevant.
After delivery, remarkable structural and functional
changes occur in the uterus to re-establish the non-pregnant
condition, starting immediately upon placenta delivery and
continuing for the following 6–8 weeks. This transition
involves the spiral arteries, whose high capacitance prop-
erties are no longer necessary; as a result, the lumen is
obliterated through thrombosis, endarteritis, and intima
thickening [26]. Despite the substantial vascularization that
is still present [18], the occlusion increases the local vas-
cular resistance [27, 28]. The immediate cause for these
events is the pressure imposed by the brisk postpartum
myometrium contraction, but there is evidence that it may
also be mediated immunologically because defects in
complement expression have been observed in cases of
placental site subinvolution [29].
In our investigation, the uterine artery PI was assessed
during the recognised period of uterine involution; based
on the study design, we are convinced that the changes
reflected are quite specific and intrinsic patterns of post-
partum involution as variables associated with labour dif-
ferences were precluded. In this study, we examined the
uterine arterial circulation after caesarean section in the
absence of labour, which ensured the absence of any con-
founding effect related to other modes of delivery (spon-
taneous vaginal, ventouse, or forceps) and labour-related
variables such as dystocia, phase latency variability, first
stage duration, and myometrial contraction.
In normotensive women, the UtA-PI was significantly
increased during the puerperal period. Interestingly, the
mean value at the first time point, i.e., immediately before
the caesarean section, is quite similar to the previously
reported third trimester mean [30]. Although there may be
some variability in the specific postpartum period assessed,
the observed increase in the vascular resistance is consis-
tent with most studies [17–19]. Few studies report no
change [31], likely reflecting design variation.
An important novel finding in the current study concerns
the UtA-PI in women with chronic hypertension and
uncomplicated pregnancies. Again, the mean PI at the first
time point was similar to the previously reported third
trimester value in hypertensive women [30], and at the
remaining time points, the UtA-PI progressively increased
postpartum at a rate similar to that in normotensive women.
However, the UtA-PI increases at higher magnitude com-
pared with that in normotensive women. Remarkably, this
peri- and postpartum difference has been recognised at
other points during pregnancy [30]. Although the cause of
this UtA-PI increase in normotensive and hypertensive
women is unknown, the decreased concentration of locally
active compounds such as oestradiol or progesterone,
which decrease substantially after delivery [32], cannot be
ignored.
Less clear is the cause of the parallel UtA-PI increase
observed in both groups. We suspect that this trend, which
was stable and continuous despite the dramatic uterine
changes, reflects the steady and robust regulatory mecha-
nisms in the vasculature. The responsible mechanisms may
be systemic as those thought to control essential hyper-
tension [33], but they may also reflect local activity,
pregnancy-dependent factors, or genetic modulations that
collectively allow the UtA to adequately perfuse the uterus
irrespective of its pathologic condition. For example,
women of Andean ancestry exhibit a three times higher
UtA-PI compared with women of European descent,
despite living at similar altitudes; however, during preg-
nancy, the hemodynamic adjustments lead to rather similar
UtA-PIs in both [34].
An understanding of the uterine impedance recovery
during the puerperium returning to the non-pregnant con-
dition can help show the normal physiology and provide
important insights into specific disorders, with PE as the
most important one. The morbidity and mortality associ-
ated with PE cannot be overlooked, and delivery does not
completely eliminate the risk of PE and its complications,
which can become apparent when successful treatment has
been seemingly achieved [20, 35]. Indeed, PE frequently
shows up without any clinical signs or may present with
non-specific or mild symptoms [36].
A number of molecules with local and systemic action
have been shown to modulate the occurrence of PE
including nitric oxide, components of the renin–angio-
tensin system, and certain growth factors [37], but
assessment is cumbersome or clinically unfeasible. During
the puerperal period, apart from continued monitoring and
reporting of signs and symptoms, a hemodynamic
approach, such as uterine artery impedance measurement,
could be a useful way to detect impending PE or other
conditions. However, additional studies are required to
verify the diagnostic or prognostic utility of UtA Doppler
ultrasound for specific hypertensive syndromes
puerperium.
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Study limitations
The present study comprised only uneventful pregnancies
with normal neonatal and puerperal outcomes, and cannot
be extrapolated to patients with other hypertensive condi-
tions during pregnancy. Additionally, the hypertensive
patients were treated from the first trimester onwards with
daily low-dose acetylsalicylic acid and methyldopa. How-
ever, this regimen was prescribed in all the hypertensive
patients, and therefore, this confounder was not isolated in
the statistical analysis (the proportions were 100 and 0 %,
respectively).
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